Next, because a recent study showed that amplification is the major activation mechanism of KRASin GAC cancer and that KRAS amplification is significantly associated with resistance to MAPK blockade [54], we assessed copy number alterations of KRAS by subtype. This evidence concerns the gene KRAS and cancer.